EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Psychometric Properties of the Drug Stigma Scale Among Community Pharmacists Concerning Individuals Who Use Over‐The‐Counter Drugs

Munenori Katayama iD, Takuya Shimane, Norihito Shirakawa, Kanna Sugiura, Ken Inada, Jun Konishi, Yoshihito Sakurai, Keiji Kobara, So Fujishiro, Toshihiko Matsumoto iD

Neuropsychopharmacology Reports · 2026-03 · 46 (1)

DOI: 10.1002/npr2.70101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, online erschienen am 03.03.2026. Verfasst von Munenori Katayama und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan. Hauptthemen laut MEDLINE: Nonprescription Drugs, Pharmacists, Psychometrics, Social Stigma. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Health, Labour and Welfare, Nationwide Addiction Center Research Project, led by the Japanese Ministry of Health, Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Stigma among pharmacists toward individuals who use over‐the‐counter (OTC) drugs for unintended purposes may hinder effective support. This study aimed to assess the psychometric properties of the Drug Stigma Scale (DSS) when applied to pharmacists and to examine the factors associated with stigma levels in this context.

Methods

A survey was anonymously distributed to pharmacists attending voluntary online workshops organized by a prefectural pharmaceutical association in Japan from August 2023 to March 2024. These workshops focused on OTC drug use for unintended purposes and the gatekeeping role of pharmacists. A total of 490 responses were analyzed. The DSS, originally a 24‐item scale developed for the Japanese context, was adapted to specify “OTC drug use.” Confirmatory factor analysis (CFA) and internal consistency analyses were conducted. Concurrent validity was assessed using correlations and group comparisons based on demographic variables, confidence in knowledge, and gatekeeper self‐efficacy (GKSES).

Results

The adapted 18‐item structure of the DSS demonstrated a good model fit (CFI = 0.93, TLI = 0.91, GFI = 0.92, RMSEA = 0.061). Internal consistency ranged between α = 0.68 and 0.88. Female pharmacists scored significantly lower on several subscales than male pharmacists, indicating less stigmatizing attitudes. Additionally, lower DSS scores were observed among pharmacists who had frequent contact with individuals who misuse OTC drugs, had a family history of such misuse, or sought help for related issues. The correlations between the DSS and GKSES scores were weak but significant.

Conclusion

The DSS is a valid tool for measuring stigma among pharmacists concerning OTC drug use. The findings suggest that direct or familial experiences with OTC drug misuse may reduce stigmatized attitudes. Efforts to reduce stigma should extend beyond knowledge‐based interventions and consider community engagement and opportunities for pharmacists to hear individuals' lived experiences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nonprescription DrugsPharmacistsPsychometricsSocial StigmaAttitude of Health PersonnelHealth Knowledge, Attitudes, PracticeHumansFemaleMaleAdultJapanSurveys and QuestionnairesMiddle Aged

Stichwörter der Autor:innen

drug stigma scaleover‐the‐counter drugspharmaciststigma

Substanzen

Nonprescription Drugs

Autor:innen und Institutionen

  • Department of Psychiatry, School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.
  • Department of Drug Dependence Research, Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.
  • Makoto Kokorono Clinic, Tokyo, Kanagawa, Japan.
  • Department of Community Mental Health and Law, Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Mental Health and Welfare Center, Yokohama, Kanagawa, Japan.
  • Matsugaoka Hospital, Izumo, Shimane, Japan.

ORCID-Profile: Munenori Katayama, Toshihiko Matsumoto

Förderung

  • Ministry of Health, Labour and Welfare
  • Nationwide Addiction Center Research Project, led by the Japanese Ministry of Health, Labour and Welfare

Zitieren

APA

Katayama, M., Shimane, T., Shirakawa, N., Sugiura, K., Inada, K., Konishi, J., Sakurai, Y., Kobara, K., Fujishiro, S., & Matsumoto, T. (2026). Psychometric Properties of the Drug Stigma Scale Among Community Pharmacists Concerning Individuals Who Use Over‐The‐Counter Drugs. Neuropsychopharmacology Reports, 46(1). https://doi.org/10.1002/npr2.70101

Vancouver

Katayama M, Shimane T, Shirakawa N, Sugiura K, Inada K, Konishi J, et al. Psychometric Properties of the Drug Stigma Scale Among Community Pharmacists Concerning Individuals Who Use Over‐The‐Counter Drugs. Neuropsychopharmacology Reports. 2026;46(1). doi:10.1002/npr2.70101

BibTeX
@article{Katayama2026,
  author = {Katayama, Munenori and Shimane, Takuya and Shirakawa, Norihito and Sugiura, Kanna and Inada, Ken and Konishi, Jun and Sakurai, Yoshihito and Kobara, Keiji and Fujishiro, So and Matsumoto, Toshihiko},
  title = {Psychometric Properties of the Drug Stigma Scale Among Community Pharmacists Concerning Individuals Who Use Over‐The‐Counter Drugs},
  journal = {Neuropsychopharmacology Reports},
  year = {2026},
  volume = {46},
  number = {1},
  doi = {10.1002/npr2.70101}
}
Kostenlos starten →